Geography, generalisability, and susceptibility in clinical trials.
Clougherty JE, Kinnee EJ, Cardet JC, Mauger D, Bacharier L, Beigelman A, Blake KV, Cabana MD, Castro M, Chmiel JF, Covar R, Fitzpatrick A, Gaffin JM, Gentile D, Israel E, Jackson DJ, Kraft M, Krishnan JA, Kumar HV, Lang JE, Lazarus SC, Lemanske RF Jr, Lima J, Martinez FD, Morgan W, Moy J, Myers R, Naureckas ET, Ortega VE, Peters SP, Phipatanakul W, Pongracic JA, Ross K, Sheehan WJ, Smith LJ, Solway J, Sorkness CA, Wechsler ME, Wenzel S, White SR, Holguin F.
Clougherty JE, et al.
Lancet Respir Med. 2021 Apr;9(4):330-332. doi: 10.1016/S2213-2600(21)00046-1. Epub 2021 Feb 1.
Lancet Respir Med. 2021.
PMID: 33539731
Free PMC article.
No abstract available.